Regeneron begins coronavirus antibody cocktail late-stage trial
July 06, 2020 at 07:20 AM EDT
Regeneron Pharmaceuticals said on Monday it began late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating Covid-19.
